Clinical Trial

A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers

Recruiting
View on ClinicalTrials.gov →
Summary
The overall purpose of this study will be to assess primary combustible cigarette users' abstinence from smoking their usual brand of combustible cigarettes at the end of the study, when provided with an electronic nicotine delivery system (ENDS) power unit (2) and varying levels of access to tobacco-flavored, menthol-flavored, mint, or non-tobacco/non-menthol/non-mint-flavored cartridge-based e-liquids (collectively referred to as the investigational product) within their assigned study arm over a three-month (ninety-day) period.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-04
Trial Details
NCT Number NCT07598136
Lead Sponsor RAI Services Company
Conditions Smoking, Tobacco
Enrollment 1,280 participants
Start Date 2026-05-14
Primary Completion 2026-12-17 (estimated)
Study Completion 2027-01-21 (estimated)
Updated on ClinicalTrials.gov 2026-06-03